Dacogen 50 mg · CNK 2981371

Product information

Dacogen 50 mg
50 mg
2981371
0 / 10
Locked

Product properties

L01BC08
Janssen-Cilag International
Powder for concentrate for solution for infusion
€1,034.57
EU/1/12/792/001
05413868106336
M44
Public
428626-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Stop reimbursement) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Stop reimbursement

Alternative available
Available
Until 30/04/2026

Composition

3 ingredients

Substance Type Strength CAS
Active ingredient
50 mg
2353-33-5
Excipient
Excipient

Additional information

View on BCPI

Availability statistics

Commercialization stopped
153 days
4
0
01/05/2026